News GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 11:04:08 16/02/2026 GMT			5-day change	1st Jan Change
2,181.00 ^GBX	+0.74%		+0.95%	+19.45%

02-13	GSK : Receives a Buy rating from Jefferies	ZD
02-13	Bernstein, Barclays and Deutsche lower Relx	AN

All News

02-13	GSK : Receives a Buy rating from Jefferies	ZD
02-13	Bernstein, Barclays and Deutsche lower Relx	AN
02-13	NatWest results ahead of forecasts, ups dividend 51%	AN
02-13	Sanofi's new CEO needs to fix drug pipeline and navigate Trump	RE
02-12	Intron Health Downgrades GSK to Sell Rating, Lifts PT	MT
02-12	Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant	RE
02-12	Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant	RE
02-11	Bernstein Upbeat on GSK Amid Upcoming Catalysts; Price Target, Forecasts Revised	MT
02-10	FDA refuses to review Moderna's influenza vaccine application	RE
02-10	European Stocks Mostly Lower in Tuesday Trading; UK Regulator Seeks Views on Apple, Google Competition Commitments	MT
02-10	Quest Diagnostics Incorporated announces an Increase in Equity Buyback	CI
02-10	Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.	CI
02-10	GSK's RSV Vaccine Arexvy Accepted for Regulatory Review in China for Older Adults	MT
02-10	GSK RSV vaccine Arexvy accepted for review in China for adults over 60	AN
02-10	GSK says regulatory decision on Arexvy expected in 2027	RE
02-10	Chinese Regulator Accepts GSK's Arexvy Vaccine for Review	MT
02-10	GSK : RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older	PU
02-10	GSK plc's RSV Vaccine Accepts for Review by China's Center for Drug Evaluation for the Prevention of Lower Respiratory Syncytial Virus Disease	CI
02-09	Deutsche cuts Unilever; Jefferies cuts Greggs	AN
02-06	European Stocks Track Higher in Friday Trading; Stellantis Tanks on $26.5 Billion Write-Down	MT
02-06	GSK Chair Jonathan Symonds buys GBP53,000 in shares	AN
02-06	GSK plc Announces Nucala (Mepolizumab) Approval by European Commission for Treatment of Chronic Obstructive Pulmonary Disease	CI
02-06	Markets Ask the Obvious Question
02-06	GSK Says European Commission Approves Nucala to Treat Chronic Obstructive Pulmonary Disease	MT
02-06	Oddo BHF cuts Wizz Air and Ryanair	AN